Seeking Alpha

Pfizer sues Indian company over Viagra

  • Pfizer (PFE) has sued to prevent India's Torrent Pharmaceuticals from selling a generic version of Viagra until the drug's patent expires in October 2019.
  • Pfizer's action comes after Torrent filed to market a copycat form of the product before the patent ends.
  • The stakes are high, as Viagra generated $1.88B in sales last year, or 3.6% of Pfizer's total revenue
  • Pfizer has sued other firms over the same issue and has reached an agreement with Teva (TEVA) that would allow the Israeli company to start selling generic Viagra in December 2017 or earlier under certain circumstances.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|